Increasing demand for weight-loss jabs such as Mounjaro and Wegovy has helped sales at the firm behind online
pharmacy Chemist4U almost double.
The Skelmersdale-based business has reported a turnover of £59.5m for the year to 30 September, 2024, according to
new accounts filed with
Companies House.
The latest total comes after the firm behind Chemist4U achieved a turnover of £30.1m in the prior 12 months.
The results also show its pre-tax profit jumped rom £1.6m to £3.6m over the same period.
Chemist4U is part of JCCO Healthcare, which also includes the weight management platform myBMI.
The latest accounts for JCCO Healthcare show its turnover also surged from £30.8m to
£63.1m and its pre-tax profit grew from £1.6m to £5m.
Mounjaro Rollout on the NHS Starts
The results have been published on the same day as the mass rollout of weight loss jabs on the NHS in England
began – with GPs now allowed to prescribe the drugs for the first time.
Around 220,000 people with “greatest need” are expected to receive Mounjaro, also known as tirzepatide and made by
Eli Lilly through the NHS over the next three years.
The drug is an antidiabetic drug which lowers blood sugar levels and and slows down how quickly food is
digested.
From today (Monday, June 23), GPs in England will be allowed to prescribe Mounjaro to severely obese people who
also suffer from a range of other health problems.
Patients previously needed to access the drugs through a special weight loss service.
In the first year of the programme, the drug will be offered to people with a body mass index (BMI) score of over
40 who have at least four other health problems linked to obesity, such as type 2 diabetes; high blood pressure;
heart disease; and obstructive sleep apnoea.
Estimates suggest around 1.5m people in the UK are already taking weight loss drugs, which may have been
prescribed through specialist weight loss services or via private prescription.
NHS Pressures Boost Chemist4U
A statement signed off by the board said: “Continued downward pressure from central government on NHS funding and
therefore the NHS pharmacy incomes, combined with inflationary pressures on raw material costs and sustained
competition in the second continue to create margin pressure.
“The directors, however, consider the company’s financial position and performance to be satisfactory given the
current economic fundamentals within the markets in which the business operates.”
The results come after Bolton-based Pitalia Capital invested £12m in the company in 2023.
The firm is an equity investment company funded by Anil Pitalia, founder of SpaMedica, and specialises in
healthcare and manufacturing.
The Future of Weight Loss Drugs and Online Pharmacies: Trends and Projections
The surging demand for weight-loss medications like Mounjaro and Wegovy is reshaping the healthcare landscape.
This article explores the potential future trends related to these themes, offering insights for consumers,
healthcare professionals, and investors.
The Expanding Market for Weight Loss Solutions
The recent financial success of Chemist4U, as highlighted in the news, underscores a significant trend: the
growing popularity of weight loss drugs. This isn’t just a temporary surge; the market is poised for continued
expansion.
Did you know? The global weight loss market is projected to reach billions of dollars in the next few years.
This growth is fueled by rising obesity rates, increased awareness, and the effectiveness of new medications.
Key Drivers of Growth
- Accessibility: Online pharmacies like Chemist4U are making it easier for people to access these
medications, removing geographical barriers. - Effectiveness: Medications like Mounjaro and Wegovy have demonstrated significant results in clinical
trials, leading to increased patient interest. - Healthcare System Shifts: The NHS rollout of Mounjaro reflects a broader acceptance of these
treatments as a viable approach to managing obesity-related conditions.
Telehealth and Online Pharmacies: A Perfect Match
The rise of online pharmacies is closely intertwined with the growth of telehealth. Virtual consultations allow
patients to connect with healthcare providers remotely, streamlining the prescription process.
Pro Tip: When selecting an online pharmacy, always check for licensed professionals, verified
prescriptions, and secure data protection. Prioritize your health and safety.
Benefits of Online Pharmacies
- Convenience: Patients can access medications from the comfort of their homes, saving time and
effort. - Cost-Effectiveness: Online pharmacies often offer competitive pricing, reducing out-of-pocket
expenses. - Privacy: Some individuals prefer the discretion of online services, avoiding in-person clinic
visits.
Future Trends and Innovations
The weight loss industry is dynamic, with continuous advancements. Several trends are likely to shape the future.
Personalized Medicine
As research evolves, we can anticipate treatments tailored to individual genetic profiles and metabolic needs. This
precision medicine approach promises more effective and safer outcomes.
Combination Therapies
Combining weight loss medications with lifestyle interventions, such as diet and exercise programs, is likely to
become more prevalent. This holistic approach aims to provide sustainable results.
Technological Integration
Wearable devices and health apps will play a greater role in monitoring progress, providing real-time feedback, and
motivating patients. These tools will enhance patient engagement and adherence to treatment plans.
Challenges and Considerations
While the future of weight loss drugs and online pharmacies looks promising, some challenges remain.
Drug Availability and Cost
Demand may outstrip supply, especially for newer medications. Affordability is another concern, with high prices
potentially limiting access for some individuals.
Side Effects and Safety
Like all medications, weight loss drugs can cause side effects. It’s important to consult with a healthcare
Worth a look